Categoría

Áreas Terapéuticas

Home > Áreas Terapéuticas (Page 22)

Llamas-Velasco M, Sánchez-Pérez J, Castañeda S, Vicente-Rabaneda EF, Pardo J, Márquez J, Armesto S, Belinchón I, Yébenes M, Casado A

 

 

Coste de la enfermedad en los pacientes con psoriasis y artritis psoriásica. Estudio COEPSO
Congreso Academia Española de Dermatología y Venereología (AEDV). Virtual. 19-21 nov 2020

de Andrés-Nogales F, Cruz E, Calleja MÁ, Delgado O, Gorgas -Torner MQ, Espin J, Mestre-Ferrandiz J, Palau F, Ancochea A, Arce R, Domínguez-Hernández R, Casado MA, FinMHU-MCDA Group

 

A Multi-Stakeholder Multicriteria Decision Analysis in Rare Diseases: Reimbursement Criteria for Orphan Drugs in Spain (FinMHU-MCDA study)
23rd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Virtual. 16-19 nov 2020

POSTER

Ferrando R , Echave M , Espinoza Cámac N , Maratia S , Casado MA

 

 

Cost Analysis of Work and Household Productivity Improvements with Certolizumab Pegol in Patients with NON-Radiographic Axial Spondyloarthritis in Spain
23rd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Virtual. 16-19 nov 2020

POSTER

Coll P, Jarrín I, Martínez E, Martínez-Sesmero JM, Domínguez-Hernández R, Casado MA

 

 

Achieving 2030 UNAIDS goals in human immunodeficiency virus individuals: a simulation model to prioritize interventions for decision making
23rd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Virtual. 16-19 nov 2020

POSTER

Esteban R, Domínguez-Hernández R, Casado MA

 

 

 

Economic and outcomes-related value of sofosbuvir-based regimens for chronic hepatitis C in Spain
23rd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Virtual. 16-19 nov 2020

POSTER

Forns X, Colom J, García-Retortillo M, Quer JC, Lens S, Domínguez-Hernández R, Casado MA, Buti M

 

 

Point-Of-Care hepatitis C testing and treating strategy in people who inject drugs in harm reduction and addiction centers for hepatitis C elimination
The Liver Meeting digital experience (AASLD). Virtual 13-16 nov 2020